Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Semler Scientific (NASDAQOTCBB:SMLR)

CAPS Rating: 4 out of 5

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

How do you think NASDAQOTCBB:SMLR will perform against the market?

Add Stock to CAPS Watchlist

All Players

155 Outperform
5 Underperform
 

All-Star Players

34 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQOTCBB:SMLR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

VIPMember (< 20)
Submitted January 05, 2021

in Feroldi I trust. 10 bagger

SmartAce (99.53)
Submitted May 08, 2018

My toddler just asked, "Where's mom?" and I told him to go ask his mom.

NASDAQOTCBB:SMLR VS S&P 500 (SPY)

NASDAQOTCBB:SMLR Summary

Fools bullish on NASDAQOTCBB:SMLR are also bullish on:

Fools bearish on NASDAQOTCBB:SMLR are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about SMLR.

Recs

0
Member Avatar IndyAnthony (41.87) Submitted: 4/12/2021 11:41:56 PM : Outperform Start Price: $110.00 NASDAQ OTC:SMLR Score: +1.35

Huuge potential with QuantaFlo healthcare product that measures blood flow in a patient in about 4 minutes time. SaaS-like business model with a mrk cap < $1B at the moment. Could easily be a $10B+ business.

Recs

0
Member Avatar FoolGrowth4Life (< 20) Submitted: 3/13/2021 8:37:26 AM : Outperform Start Price: $107.25 NASDAQ OTC:SMLR Score: -0.45

The ability to identify life-threatening diseases early and in asymptomatic patients with high accuracy rates is priceless. To be able to accomplish this feat while contributing to making healthcare costs lower for patients and providers is game-changing. Semler Scientific, Inc. is doing exactly that with their patented QuantaFlo technology and proprietary risk assessment software for physicians and health insurance companies.

Insider Ownership: 26%
Debt- Free
$22M in Cash
Market Cap: under $1B
Forecasted Earnings Growth: 27%
ROCE: 53%, ROA: 40%, ROE: 47%, very fiscally responsible and rewarding to their shareholders
4 New products in different development stages that will continue to expand optionality and revenue streams

Semler scientific is not resting on its laurels and success of QuantaFlo Technology, Software as a Service Platform, and their Wellchec Testing Service for their customers. Instead Semler Scientific is thinking about things in a holistic approach by wanting to build a platform or ecosystem of health products and services that integrate and complement the solutions they have today. Semler Scientific is working with three different private firms to create three different healthcare solutions that are patented, already FDA approved, and will continue to help save lives like QuantaFlo.
The Semler Scientific Ecosystem could grow its revenue streams and customer base tremendously if these solutions can identify potential healthcare risks early like QuantaFlo has, save patients time with healthcare visits, and provide more accurate results. I am confident they will deliver on this type of platform and they also have another internal product being developed which brings the total to four new solutions they will be launching in the future. If Semler can replicate the financial success they have currently with these new products then they could have large compounded growth returns for a long time.

Recs

0
Member Avatar dschleicher (81.09) Submitted: 3/2/2021 2:29:12 PM : Outperform Start Price: $118.60 NASDAQ OTC:SMLR Score: -12.20

Great profit margins and lots of optionality

Leaderboard

Find the members with the highest scoring picks in SMLR.

Score Leader

mingdom

mingdom (97.75) Score: +365.13

The Score Leader is the player with the highest score across all their picks in SMLR.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
mingdom 97.75 8/13/2018 Outperform 5Y $22.10 +413.57% +48.44% +365.13 0 Comment
Paco57 64.55 8/17/2018 Outperform 5Y $23.00 +393.48% +47.36% +346.12 1 Comment
Plasmidologist 61.11 9/24/2018 Outperform 5Y $34.20 +231.84% +43.91% +187.93 0 Comment
sublimeinvestor 39.45 9/24/2018 Outperform 5Y $34.20 +231.84% +43.91% +187.93 0 Comment
Dreamwolves 56.23 10/3/2018 Outperform 1Y $38.55 +194.42% +43.15% +151.27 0 Comment
jerseymike89 31.91 7/8/2020 Outperform 5Y $44.00 +157.95% +33.35% +124.60 0 Comment
LK15833 49.31 5/12/2020 Outperform 5Y $43.00 +163.95% +42.55% +121.40 0 Comment
UnderdogIsHere < 20 7/10/2020 Outperform 5Y $45.60 +148.90% +31.98% +116.92 0 Comment
grahamglen3030 92.49 5/6/2020 Outperform 5Y $43.34 +161.88% +45.50% +116.38 0 Comment
Randalf 47.21 5/6/2020 Outperform 5Y $43.34 +161.88% +45.50% +116.38 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SMLR.